You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,670,335


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,670,335
Title: Fluorouracil-containing formulation
Abstract:Oil-in-water emulsion formulations contain both free fluorouracil and fluorouracil impregnated in porous microparticles. The formulations are suitable for topical administration, and are useful for the treatment of solar keratoses, actinic keratoses, and superficial basal cell carcinomas.
Inventor(s): Singh; B. Sandhya (San Jose, CA), Saxena; Subhash J. (Belmont, CA)
Assignee: A. P. Pharma, Inc. (Redwood City, CA)
Application Number:09/799,792
Patent Claim Types:
see list of patent claims
Formulation; Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,670,335

Introduction

United States Patent 6,670,335, titled "Fluorouracil-containing formulation," is a significant patent in the pharmaceutical field, particularly in the area of cancer treatment. This patent, issued to a specific inventor or assignee, details a unique formulation of fluorouracil, a widely used chemotherapeutic agent.

Background of Fluorouracil

Fluorouracil is a fluorinated pyrimidine analog that has been a cornerstone in the treatment of various cancers, including colorectal, breast, and skin cancers. Its efficacy and mode of action make it a crucial component in many chemotherapy regimens.

Patent Overview

The patent US6670335B2 describes an oil-in-water emulsion formulation that contains both free fluorouracil and fluorouracil impregnated in porous microparticles. This formulation is designed to enhance the delivery and efficacy of fluorouracil.

Key Components of the Formulation

  • Free Fluorouracil: This component is directly available for immediate action upon administration.
  • Fluorouracil Impregnated in Porous Microparticles: These microparticles release fluorouracil in a controlled manner, providing a sustained release profile. This can improve the therapeutic index by reducing peak concentrations and maintaining effective levels over a longer period[1].

Claims of the Patent

The patent includes several claims that define the scope of the invention:

Independent Claims

  • Claim 1 typically describes the broadest aspect of the invention, which in this case is the oil-in-water emulsion formulation containing fluorouracil.
  • Subsequent claims narrow down the scope by specifying particular aspects such as the composition of the microparticles, the method of preparation, and specific ratios of free to impregnated fluorouracil.

Dependent Claims

  • These claims build upon the independent claims and provide additional details or limitations. For example, they might specify the size range of the microparticles, the type of oil used in the emulsion, or the method of administering the formulation.

Patent Landscape Analysis

Understanding the patent landscape around US6670335B2 is crucial for several reasons:

Saturation of the Patent Space

The area of cancer treatment, particularly formulations of chemotherapeutic agents, is highly saturated with patents. A comprehensive patent landscape analysis helps in identifying existing patents, pending applications, and competitors in this space. This analysis can guide decisions on whether to continue research and development in this area or to pivot to newer, less saturated technologies[3].

Competitor Analysis

Identifying key players and their patent portfolios in the field of fluorouracil formulations can provide insights into market competition. Companies with significant patent holdings in this area may be major competitors, and understanding their strategies can help in developing a competitive edge.

Opportunities and Challenges

A patent landscape analysis can reveal opportunities for innovation by identifying gaps in current technologies. It can also highlight challenges, such as the need to navigate around existing patents to avoid infringement.

Strategic Insights

Market Positioning

Companies holding patents like US6670335B2 can leverage these to secure market positions. By understanding the patent landscape, they can identify areas where they have a competitive advantage and focus their marketing and sales efforts accordingly.

Licensing and Collaboration

Patents can be valuable assets for licensing or collaboration. A thorough analysis of the patent landscape can help identify potential partners or licensees who could benefit from the technology described in US6670335B2.

Valuation of the Patent

The value of a patent like US6670335B2 can be significant, given its potential impact on cancer treatment. The valuation methods for patents include:

Cost Approach

This method considers the costs incurred in developing the patent, including research, development, and legal fees[4].

Income Approach

This method evaluates the future income or savings generated by the patent over its lifetime. For a patent like US6670335B2, this could include royalties from licensing or sales of the formulation.

Market Approach

This method determines the value based on what a willing buyer would pay for a similar asset. Historical sales data of similar patents can provide benchmarks for valuation.

Enforcement and Litigation

Small Claims Patent Court

For smaller entities or individuals holding patents like US6670335B2, the concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could provide a more accessible and cost-effective way to enforce patent rights[5].

Key Takeaways

  • Unique Formulation: The patent describes a unique oil-in-water emulsion formulation of fluorouracil with both free and microparticle-impregnated forms.
  • Patent Landscape: The area of cancer treatment is highly saturated, requiring a comprehensive patent landscape analysis to navigate.
  • Strategic Insights: Understanding the patent landscape can guide market positioning, licensing, and collaboration strategies.
  • Valuation: The patent's value can be determined using cost, income, and market approaches.
  • Enforcement: Small claims patent courts could offer a viable option for enforcing patent rights.

FAQs

  1. What is the main innovation described in US Patent 6,670,335?

    • The main innovation is an oil-in-water emulsion formulation containing both free fluorouracil and fluorouracil impregnated in porous microparticles.
  2. Why is a patent landscape analysis important for this patent?

    • It helps in understanding the competitive landscape, identifying opportunities and challenges, and guiding strategic decisions.
  3. How can the value of this patent be determined?

    • The value can be determined using the cost, income, and market approaches.
  4. What are the potential benefits of a small claims patent court for holders of this patent?

    • It could provide a more accessible and cost-effective way to enforce patent rights.
  5. How does this patent impact the treatment of cancer?

    • It enhances the delivery and efficacy of fluorouracil, a widely used chemotherapeutic agent, by providing a sustained release profile.

Sources

  1. US6670335B2 - Fluorouracil-containing formulation - Google Patents
  2. Nonprovisional (Utility) Patent Application Filing Guide - USPTO
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP
  4. The value of a patent - Perpetual Motion Patents
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,670,335

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.